A Phase 1a/b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of NTR-1011 in Healthy Adults and Adult Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)
Phase: PHASE1 | Sponsor: Neutrolis | Compound: Psychedelic
- Status
- recruiting
- Institution
- Neutrolis
- Start date
- 2025-09-04
- End date
- 2026-01-07
- Registry ID
- NCT07237659
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.